Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and ...

The toxic haze that blanketed large parts of India in November didn’t just cloud the skies—it pushed sales of asthma and COPD medicines to their highest levels in three years.

Cipla is currently trading at Rs 1518.80, showing a percentage change of 0.72% today, with a 3-day exponential moving average of Rs 1513.63. Cipla has recently surpassed its 20-day Exponential Moving ...

Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) can cause side effects that range from mild to serious. If side effects from Breztri become ...

Cipla's stock is priced at Rs 1506.90, reflecting a percentage change of 0.20% for today. The current 3-day simple moving average (SMA3) is Rs 1504.87. Cipla is currently valued at Rs 1515.30, marking ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent. By Rebecca ...

ALBANY, N.Y. (NEWS10)—Making asthma inhalers more affordable— new legislation signed by Governor Hochul will eliminate out of pocket costs for the lifesaving medication. “It should not cost so much to ...

New Yorkers with asthma may soon be able to breathe a little easier. Gov. Kathy Hochul signed legislation Monday that will make inhalers free for many New Yorkers starting in 2027. Under the new law, ...